RABI F, ALI A, BAHAR S, LIAQAT M, NAYAB D, ALI B, WAZIR S. EFFECT OF DAPAGLIFLOZIN ON CARDIOVASCULAR OUTCOMES IN HFREF PATIENTS: IMPACT OF DIABETES MELLITUS TYPE 2 STATUS. Biol Clin Sci Res J [Internet]. 2024May5 [cited 2025Aug.2];2024(1):830. Available from: https://www.bcsrj.com/ojs/index.php/bcsrj/article/view/830